How surgery startups trap patients

A mix of fear and urgency has made it easy for online health companies to convince people to undergo surgeries.

28 July, 202210 min
0
How surgery startups trap patients

Why read this story?

Editor's note: Last year, after experiencing acute pain in his lower back and frequent constipation for two months, M, a 35-year-old corporate executive, decided to enquire about treatment on Gurugram-based online healthcare platform Pristyn Care. The process was straightforward. He clicked on “Piles” and a list of proctologists in his city appeared. M chose the doctor with the highest rating and requested a callback. Half an hour later, he received a call, from a sales representative and not a doctor, as he was expecting. Apart from providing his age and other basic information, M mentioned that he’d had nothing more than a basic diagnosis of haemorrhoids. At this, the Pristyn Care representative suddenly seemed excited. “He sounded happier than a child who was offered candy,” recalls M. Five minutes into the conversation, the sales representative threw a curveball: “Sir, at least 40% of people with haemorrhoids develop cancer in a few years and this percentage is only increasing. With your flourishing corporate career, I’m sure you don’t want to risk it!” Even as M was trying to make sense of what this …

You may also like

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.

Internet
Story image

FabHotels pivoted to corporate travel for survival. Can it grow?

The challenges of running a budget hotel chain in India forced the decade-old company to quietly shift its focus to a travel management platform for corporate travellers. Now it must face challenges of another kind.

Business
Story image

Duroflex wakes up as Wakefit closes in on an IPO

The six-decade old mattress maker files its draft IPO papers just as Wakefit wins approval for a public market debut—setting up a bruising battle for the No. 2 spot.